Cargando…
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
AIMS: The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory myopathy (IIM) research community. This inaugural report examines pooled Registry data. METHODS: Cross-sectional analysis of IIM cases from 11 countries was performed. Associations between clinical subtypes,...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754739/ https://www.ncbi.nlm.nih.gov/pubmed/28855174 http://dx.doi.org/10.1136/annrheumdis-2017-211868 |
_version_ | 1783290481831051264 |
---|---|
author | Lilleker, James B Vencovsky, Jiri Wang, Guochun Wedderburn, Lucy R Diederichsen, Louise Pyndt Schmidt, Jens Oakley, Paula Benveniste, Olivier Danieli, Maria Giovanna Danko, Katalin Thuy, Nguyen Thi Phuong Vazquez-Del Mercado, Monica Andersson, Helena De Paepe, Boel deBleecker, Jan L Maurer, Britta McCann, Liza J Pipitone, Nicolo McHugh, Neil Betteridge, Zoe E New, Paul Cooper, Robert G Ollier, William E Lamb, Janine A Krogh, Niels Steen Lundberg, Ingrid E Chinoy, Hector |
author_facet | Lilleker, James B Vencovsky, Jiri Wang, Guochun Wedderburn, Lucy R Diederichsen, Louise Pyndt Schmidt, Jens Oakley, Paula Benveniste, Olivier Danieli, Maria Giovanna Danko, Katalin Thuy, Nguyen Thi Phuong Vazquez-Del Mercado, Monica Andersson, Helena De Paepe, Boel deBleecker, Jan L Maurer, Britta McCann, Liza J Pipitone, Nicolo McHugh, Neil Betteridge, Zoe E New, Paul Cooper, Robert G Ollier, William E Lamb, Janine A Krogh, Niels Steen Lundberg, Ingrid E Chinoy, Hector |
author_sort | Lilleker, James B |
collection | PubMed |
description | AIMS: The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory myopathy (IIM) research community. This inaugural report examines pooled Registry data. METHODS: Cross-sectional analysis of IIM cases from 11 countries was performed. Associations between clinical subtypes, extramuscular involvement, environmental exposures and medications were investigated. RESULTS: Of 3067 IIM cases, 69% were female. The most common IIM subtype was dermatomyositis (DM) (31%). Smoking was more frequent in connective tissue disease overlap cases (45%, OR 1.44, 95% CI 1.09 to 1.90, p=0.012). Smoking was associated with interstitial lung disease (ILD) (OR 1.32, 95% CI 1.06 to 1.65, p=0.013), dysphagia (OR 1.43, 95% CI 1.16 to 1.77, p=0.001), malignancy ever (OR 1.78, 95% CI 1.36 to 2.33, p<0.001) and cardiac involvement (OR 2.40, 95% CI 1.60 to 3.60, p<0.001). Dysphagia occurred in 39% and cardiac involvement in 9%; either occurrence was associated with higher Health Assessment Questionnaire (HAQ) scores (adjusted OR 1.79, 95% CI 1.43 to 2.23, p<0.001). HAQ scores were also higher in inclusion body myositis cases (adjusted OR 3.85, 95% CI 2.52 to 5.90, p<0.001). Malignancy (ever) occurred in 13%, most commonly in DM (20%, OR 2.06, 95% CI 1.65 to 2.57, p<0.001). ILD occurred in 30%, most frequently in antisynthetase syndrome (71%, OR 10.7, 95% CI 8.6 to 13.4, p<0.001). Rash characteristics differed between adult-onset and juvenile-onset DM cases (‘V’ sign: 56% DM vs 16% juvenile-DM, OR 0.16, 95% CI 0.07 to 0.36, p<0.001). Glucocorticoids were used in 98% of cases, methotrexate in 71% and azathioprine in 51%. CONCLUSION: This large multicentre cohort demonstrates the importance of extramuscular involvement in patients with IIM, its association with smoking and its influence on disease severity. Our findings emphasise that IIM is a multisystem inflammatory disease and will help inform prognosis and clinical management of patients. |
format | Online Article Text |
id | pubmed-5754739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57547392018-02-12 The EuroMyositis registry: an international collaborative tool to facilitate myositis research Lilleker, James B Vencovsky, Jiri Wang, Guochun Wedderburn, Lucy R Diederichsen, Louise Pyndt Schmidt, Jens Oakley, Paula Benveniste, Olivier Danieli, Maria Giovanna Danko, Katalin Thuy, Nguyen Thi Phuong Vazquez-Del Mercado, Monica Andersson, Helena De Paepe, Boel deBleecker, Jan L Maurer, Britta McCann, Liza J Pipitone, Nicolo McHugh, Neil Betteridge, Zoe E New, Paul Cooper, Robert G Ollier, William E Lamb, Janine A Krogh, Niels Steen Lundberg, Ingrid E Chinoy, Hector Ann Rheum Dis Clinical and Epidemiological Research AIMS: The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory myopathy (IIM) research community. This inaugural report examines pooled Registry data. METHODS: Cross-sectional analysis of IIM cases from 11 countries was performed. Associations between clinical subtypes, extramuscular involvement, environmental exposures and medications were investigated. RESULTS: Of 3067 IIM cases, 69% were female. The most common IIM subtype was dermatomyositis (DM) (31%). Smoking was more frequent in connective tissue disease overlap cases (45%, OR 1.44, 95% CI 1.09 to 1.90, p=0.012). Smoking was associated with interstitial lung disease (ILD) (OR 1.32, 95% CI 1.06 to 1.65, p=0.013), dysphagia (OR 1.43, 95% CI 1.16 to 1.77, p=0.001), malignancy ever (OR 1.78, 95% CI 1.36 to 2.33, p<0.001) and cardiac involvement (OR 2.40, 95% CI 1.60 to 3.60, p<0.001). Dysphagia occurred in 39% and cardiac involvement in 9%; either occurrence was associated with higher Health Assessment Questionnaire (HAQ) scores (adjusted OR 1.79, 95% CI 1.43 to 2.23, p<0.001). HAQ scores were also higher in inclusion body myositis cases (adjusted OR 3.85, 95% CI 2.52 to 5.90, p<0.001). Malignancy (ever) occurred in 13%, most commonly in DM (20%, OR 2.06, 95% CI 1.65 to 2.57, p<0.001). ILD occurred in 30%, most frequently in antisynthetase syndrome (71%, OR 10.7, 95% CI 8.6 to 13.4, p<0.001). Rash characteristics differed between adult-onset and juvenile-onset DM cases (‘V’ sign: 56% DM vs 16% juvenile-DM, OR 0.16, 95% CI 0.07 to 0.36, p<0.001). Glucocorticoids were used in 98% of cases, methotrexate in 71% and azathioprine in 51%. CONCLUSION: This large multicentre cohort demonstrates the importance of extramuscular involvement in patients with IIM, its association with smoking and its influence on disease severity. Our findings emphasise that IIM is a multisystem inflammatory disease and will help inform prognosis and clinical management of patients. BMJ Publishing Group 2018-01 2017-08-30 /pmc/articles/PMC5754739/ /pubmed/28855174 http://dx.doi.org/10.1136/annrheumdis-2017-211868 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Clinical and Epidemiological Research Lilleker, James B Vencovsky, Jiri Wang, Guochun Wedderburn, Lucy R Diederichsen, Louise Pyndt Schmidt, Jens Oakley, Paula Benveniste, Olivier Danieli, Maria Giovanna Danko, Katalin Thuy, Nguyen Thi Phuong Vazquez-Del Mercado, Monica Andersson, Helena De Paepe, Boel deBleecker, Jan L Maurer, Britta McCann, Liza J Pipitone, Nicolo McHugh, Neil Betteridge, Zoe E New, Paul Cooper, Robert G Ollier, William E Lamb, Janine A Krogh, Niels Steen Lundberg, Ingrid E Chinoy, Hector The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title | The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title_full | The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title_fullStr | The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title_full_unstemmed | The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title_short | The EuroMyositis registry: an international collaborative tool to facilitate myositis research |
title_sort | euromyositis registry: an international collaborative tool to facilitate myositis research |
topic | Clinical and Epidemiological Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754739/ https://www.ncbi.nlm.nih.gov/pubmed/28855174 http://dx.doi.org/10.1136/annrheumdis-2017-211868 |
work_keys_str_mv | AT lillekerjamesb theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT vencovskyjiri theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT wangguochun theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT wedderburnlucyr theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT diederichsenlouisepyndt theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT schmidtjens theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT oakleypaula theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT benvenisteolivier theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT danielimariagiovanna theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT dankokatalin theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT thuynguyenthiphuong theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT vazquezdelmercadomonica theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT anderssonhelena theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT depaepeboel theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT debleeckerjanl theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT maurerbritta theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT mccannlizaj theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT pipitonenicolo theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT mchughneil theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT betteridgezoee theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT newpaul theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT cooperrobertg theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT ollierwilliame theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT lambjaninea theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT kroghnielssteen theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT lundbergingride theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT chinoyhector theeuromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT lillekerjamesb euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT vencovskyjiri euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT wangguochun euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT wedderburnlucyr euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT diederichsenlouisepyndt euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT schmidtjens euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT oakleypaula euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT benvenisteolivier euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT danielimariagiovanna euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT dankokatalin euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT thuynguyenthiphuong euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT vazquezdelmercadomonica euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT anderssonhelena euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT depaepeboel euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT debleeckerjanl euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT maurerbritta euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT mccannlizaj euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT pipitonenicolo euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT mchughneil euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT betteridgezoee euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT newpaul euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT cooperrobertg euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT ollierwilliame euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT lambjaninea euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT kroghnielssteen euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT lundbergingride euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch AT chinoyhector euromyositisregistryaninternationalcollaborativetooltofacilitatemyositisresearch |